Український Науково-Дослідний Інститут Фтизіатрії І Пульмонології Ім. Акад. Ф.Г. Яновського
Украинский научно-исследовательский институт фтизиатрии и пульмонологии им.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Український Науково-Дослідний Інститут Фтизіатрії І Пульмонології Ім. Акад. Ф.Г. Яновського, Украинский научно-исследовательский институт фтизиатрии и пульмонологии им.filedCriticalУкраїнський Науково-Дослідний Інститут Фтизіатрії І Пульмонології Ім. Акад. Ф.Г. Яновського
Priority to UA4460444ApriorityCriticalpatent/UA6099A1/en
Publication of UA6099A1publicationCriticalpatent/UA6099A1/en
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Abstract
Determination of individual sensitivity of patients with bronchial asthma to timeline is carried out through setting reaction Ea-ROK in presence of timeline in dose of 20 mkg/ml. Reaction Ea-ROK is additionally performed with doses 0.2-2.0 mkg/ml and at presence of positive reaction with all doses or two of those, or one of those, one determines sensitivity of body to minimal dose of preparation.
UA4460444A1988-07-141988-07-14Method for determination of individual sensitivity of patients with bronchial asthma to timaline
UA6099A1
(en)
Use of 2-amino-6-allyl-5,6,7,8-tetrahydro-4H-thiazolo [4,5-d] azepin for the preparation of a medicament for the treatment of Parkinson's disease, or of Parkinsonism